nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—TNNC1—Striated Muscle Contraction—TPM3—stomach cancer	0.0411	0.0967	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—DES—stomach cancer	0.0376	0.0884	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM3—stomach cancer	0.0349	0.0822	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—DES—stomach cancer	0.0319	0.0751	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—ACTC1—stomach cancer	0.0297	0.0699	CbGpPWpGaD
Levosimendan—Myocardial ischaemia—Floxuridine—stomach cancer	0.0292	0.081	CcSEcCtD
Levosimendan—TNNC1—Muscle contraction—TPM3—stomach cancer	0.0276	0.0649	CbGpPWpGaD
Levosimendan—TNNC1—hematopoietic system—stomach cancer	0.027	0.126	CbGeAlD
Levosimendan—TNNC1—Muscle contraction—DES—stomach cancer	0.0252	0.0594	CbGpPWpGaD
Levosimendan—KCNJ8—smooth muscle tissue—stomach cancer	0.0179	0.0832	CbGeAlD
Levosimendan—KCNJ11—hematopoietic system—stomach cancer	0.0165	0.077	CbGeAlD
Levosimendan—KCNJ8—pancreas—stomach cancer	0.0165	0.077	CbGeAlD
Levosimendan—PDE3A—hematopoietic system—stomach cancer	0.0162	0.0755	CbGeAlD
Levosimendan—PDE3A—smooth muscle tissue—stomach cancer	0.0143	0.0665	CbGeAlD
Levosimendan—KCNJ11—pancreas—stomach cancer	0.0135	0.0627	CbGeAlD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AFP—stomach cancer	0.0134	0.0316	CbGpPWpGaD
Levosimendan—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—JUN—stomach cancer	0.0121	0.0284	CbGpPWpGaD
Levosimendan—KCNJ8—endocrine gland—stomach cancer	0.0117	0.0543	CbGeAlD
Levosimendan—KCNJ11—lymphoid tissue—stomach cancer	0.0116	0.0542	CbGeAlD
Levosimendan—TNNC1—lymph node—stomach cancer	0.0107	0.05	CbGeAlD
Levosimendan—KCNJ8—liver—stomach cancer	0.0105	0.049	CbGeAlD
Levosimendan—Myocardial ischaemia—Irinotecan—stomach cancer	0.00994	0.0276	CcSEcCtD
Levosimendan—Myocardial ischaemia—Fluorouracil—stomach cancer	0.00952	0.0264	CcSEcCtD
Levosimendan—KCNJ11—endocrine gland—stomach cancer	0.0095	0.0443	CbGeAlD
Levosimendan—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—MAPK1—stomach cancer	0.0095	0.0223	CbGpPWpGaD
Levosimendan—PDE3A—endocrine gland—stomach cancer	0.00931	0.0434	CbGeAlD
Levosimendan—PDE3A—liver—stomach cancer	0.00839	0.0391	CbGeAlD
Levosimendan—Nervous system disorder—Floxuridine—stomach cancer	0.00821	0.0228	CcSEcCtD
Levosimendan—KCNJ8—lymph node—stomach cancer	0.00806	0.0375	CbGeAlD
Levosimendan—Haemoglobin decreased—Docetaxel—stomach cancer	0.00803	0.0223	CcSEcCtD
Levosimendan—Haemoglobin decreased—Capecitabine—stomach cancer	0.00777	0.0216	CcSEcCtD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALDOB—stomach cancer	0.00706	0.0166	CbGpPWpGaD
Levosimendan—Ventricular fibrillation—Capecitabine—stomach cancer	0.00699	0.0194	CcSEcCtD
Levosimendan—Myocardial ischaemia—Docetaxel—stomach cancer	0.00687	0.0191	CcSEcCtD
Levosimendan—Myocardial ischaemia—Capecitabine—stomach cancer	0.00666	0.0185	CcSEcCtD
Levosimendan—KCNJ11—lymph node—stomach cancer	0.00657	0.0306	CbGeAlD
Levosimendan—PDE3A—lymph node—stomach cancer	0.00644	0.03	CbGeAlD
Levosimendan—Extrasystoles—Capecitabine—stomach cancer	0.00636	0.0176	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Capecitabine—stomach cancer	0.00592	0.0164	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—RORA—stomach cancer	0.00578	0.0136	CbGpPWpGaD
Levosimendan—Diarrhoea—Floxuridine—stomach cancer	0.00573	0.0159	CcSEcCtD
Levosimendan—Cardiac failure—Fluorouracil—stomach cancer	0.00569	0.0158	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—RUNX3—stomach cancer	0.00565	0.0133	CbGpPWpGaD
Levosimendan—Vomiting—Floxuridine—stomach cancer	0.00532	0.0148	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HSPD1—stomach cancer	0.00532	0.0125	CbGpPWpGaD
Levosimendan—Hypokalaemia—Irinotecan—stomach cancer	0.00528	0.0147	CcSEcCtD
Levosimendan—Headache—Floxuridine—stomach cancer	0.00524	0.0146	CcSEcCtD
Levosimendan—Nausea—Floxuridine—stomach cancer	0.00497	0.0138	CcSEcCtD
Levosimendan—Diarrhoea—Mitomycin—stomach cancer	0.00449	0.0125	CcSEcCtD
Levosimendan—Dizziness—Mitomycin—stomach cancer	0.00434	0.0121	CcSEcCtD
Levosimendan—Atrial fibrillation—Docetaxel—stomach cancer	0.00423	0.0117	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—SLC1A2—stomach cancer	0.00418	0.00983	CbGpPWpGaD
Levosimendan—Vomiting—Mitomycin—stomach cancer	0.00418	0.0116	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HTR1A—stomach cancer	0.00417	0.00981	CbGpPWpGaD
Levosimendan—Ventricular extrasystoles—Epirubicin—stomach cancer	0.00413	0.0115	CcSEcCtD
Levosimendan—Headache—Mitomycin—stomach cancer	0.00411	0.0114	CcSEcCtD
Levosimendan—Cardiac failure—Docetaxel—stomach cancer	0.00411	0.0114	CcSEcCtD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—stomach cancer	0.00411	0.00967	CbGpPWpGaD
Levosimendan—Atrial fibrillation—Capecitabine—stomach cancer	0.0041	0.0114	CcSEcCtD
Levosimendan—Cardiac failure—Capecitabine—stomach cancer	0.00398	0.011	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1RN—stomach cancer	0.0039	0.00918	CbGpPWpGaD
Levosimendan—Nausea—Mitomycin—stomach cancer	0.0039	0.0108	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Doxorubicin—stomach cancer	0.00382	0.0106	CcSEcCtD
Levosimendan—Ventricular tachycardia—Epirubicin—stomach cancer	0.00373	0.0103	CcSEcCtD
Levosimendan—Cardiac disorder—Irinotecan—stomach cancer	0.00373	0.0103	CcSEcCtD
Levosimendan—Angiopathy—Irinotecan—stomach cancer	0.00364	0.0101	CcSEcCtD
Levosimendan—Hypokalaemia—Capecitabine—stomach cancer	0.00353	0.00981	CcSEcCtD
Levosimendan—Ventricular tachycardia—Doxorubicin—stomach cancer	0.00345	0.00957	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—MAPK8—stomach cancer	0.00305	0.00717	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—APOA1—stomach cancer	0.00296	0.00697	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.00292	0.00688	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—PPP2R1A—stomach cancer	0.00288	0.00678	CbGpPWpGaD
Levosimendan—Nervous system disorder—Irinotecan—stomach cancer	0.0028	0.00776	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL10—stomach cancer	0.00279	0.00657	CbGpPWpGaD
Levosimendan—Cardiac failure—Epirubicin—stomach cancer	0.00277	0.00769	CcSEcCtD
Levosimendan—Nervous system disorder—Fluorouracil—stomach cancer	0.00268	0.00743	CcSEcCtD
Levosimendan—Tachycardia—Fluorouracil—stomach cancer	0.00267	0.0074	CcSEcCtD
Levosimendan—Hypotension—Irinotecan—stomach cancer	0.00266	0.0074	CcSEcCtD
Levosimendan—Insomnia—Irinotecan—stomach cancer	0.00258	0.00716	CcSEcCtD
Levosimendan—Cardiac disorder—Docetaxel—stomach cancer	0.00258	0.00715	CcSEcCtD
Levosimendan—Cardiac failure—Doxorubicin—stomach cancer	0.00257	0.00712	CcSEcCtD
Levosimendan—Hypotension—Fluorouracil—stomach cancer	0.00255	0.00708	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—MAPK1—stomach cancer	0.00253	0.00596	CbGpPWpGaD
Levosimendan—Angiopathy—Docetaxel—stomach cancer	0.00252	0.00699	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB1—stomach cancer	0.0025	0.00589	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HSPA8—stomach cancer	0.00249	0.00587	CbGpPWpGaD
Levosimendan—Cardiac disorder—Capecitabine—stomach cancer	0.00249	0.00692	CcSEcCtD
Levosimendan—Insomnia—Fluorouracil—stomach cancer	0.00247	0.00686	CcSEcCtD
Levosimendan—Hypokalaemia—Epirubicin—stomach cancer	0.00246	0.00683	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00246	0.00683	CcSEcCtD
Levosimendan—Constipation—Irinotecan—stomach cancer	0.00244	0.00677	CcSEcCtD
Levosimendan—Angiopathy—Capecitabine—stomach cancer	0.00244	0.00676	CcSEcCtD
Levosimendan—Mental disorder—Docetaxel—stomach cancer	0.00243	0.00675	CcSEcCtD
Levosimendan—Malnutrition—Docetaxel—stomach cancer	0.00242	0.0067	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—stomach cancer	0.00241	0.00567	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00236	0.00654	CcSEcCtD
Levosimendan—Mental disorder—Capecitabine—stomach cancer	0.00235	0.00653	CcSEcCtD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—stomach cancer	0.00235	0.00552	CbGpPWpGaD
Levosimendan—Malnutrition—Capecitabine—stomach cancer	0.00234	0.00649	CcSEcCtD
Levosimendan—Hypokalaemia—Doxorubicin—stomach cancer	0.00228	0.00632	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—PPP2R1A—stomach cancer	0.00203	0.00477	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB2—stomach cancer	0.00203	0.00477	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—SLC1A2—stomach cancer	0.00198	0.00465	CbGpPWpGaD
Levosimendan—Diarrhoea—Irinotecan—stomach cancer	0.00195	0.00542	CcSEcCtD
Levosimendan—Nervous system disorder—Docetaxel—stomach cancer	0.00193	0.00537	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.00193	0.00453	CbGpPWpGaD
Levosimendan—Tachycardia—Docetaxel—stomach cancer	0.00192	0.00534	CcSEcCtD
Levosimendan—Dizziness—Irinotecan—stomach cancer	0.00189	0.00523	CcSEcCtD
Levosimendan—Nervous system disorder—Capecitabine—stomach cancer	0.00187	0.0052	CcSEcCtD
Levosimendan—Diarrhoea—Fluorouracil—stomach cancer	0.00187	0.00519	CcSEcCtD
Levosimendan—Tachycardia—Capecitabine—stomach cancer	0.00186	0.00517	CcSEcCtD
Levosimendan—Cardiac disorder—Methotrexate—stomach cancer	0.00186	0.00515	CcSEcCtD
Levosimendan—Hypotension—Docetaxel—stomach cancer	0.00184	0.00511	CcSEcCtD
Levosimendan—Angiopathy—Methotrexate—stomach cancer	0.00181	0.00504	CcSEcCtD
Levosimendan—Vomiting—Irinotecan—stomach cancer	0.00181	0.00503	CcSEcCtD
Levosimendan—Dizziness—Fluorouracil—stomach cancer	0.00181	0.00501	CcSEcCtD
Levosimendan—Headache—Irinotecan—stomach cancer	0.00179	0.00496	CcSEcCtD
Levosimendan—Hypotension—Capecitabine—stomach cancer	0.00178	0.00495	CcSEcCtD
Levosimendan—Insomnia—Docetaxel—stomach cancer	0.00178	0.00495	CcSEcCtD
Levosimendan—Mental disorder—Methotrexate—stomach cancer	0.00175	0.00486	CcSEcCtD
Levosimendan—Malnutrition—Methotrexate—stomach cancer	0.00174	0.00483	CcSEcCtD
Levosimendan—Cardiac disorder—Epirubicin—stomach cancer	0.00174	0.00482	CcSEcCtD
Levosimendan—Vomiting—Fluorouracil—stomach cancer	0.00174	0.00482	CcSEcCtD
Levosimendan—Insomnia—Capecitabine—stomach cancer	0.00173	0.00479	CcSEcCtD
Levosimendan—Headache—Fluorouracil—stomach cancer	0.00171	0.00475	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.0017	0.00472	CcSEcCtD
Levosimendan—Angiopathy—Epirubicin—stomach cancer	0.0017	0.00471	CcSEcCtD
Levosimendan—Nausea—Irinotecan—stomach cancer	0.00169	0.0047	CcSEcCtD
Levosimendan—Constipation—Docetaxel—stomach cancer	0.00169	0.00468	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—SERPINB2—stomach cancer	0.00167	0.00393	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00165	0.00457	CcSEcCtD
Levosimendan—Mental disorder—Epirubicin—stomach cancer	0.00164	0.00455	CcSEcCtD
Levosimendan—Constipation—Capecitabine—stomach cancer	0.00163	0.00453	CcSEcCtD
Levosimendan—Malnutrition—Epirubicin—stomach cancer	0.00163	0.00452	CcSEcCtD
Levosimendan—Nausea—Fluorouracil—stomach cancer	0.00162	0.0045	CcSEcCtD
Levosimendan—Cardiac disorder—Doxorubicin—stomach cancer	0.00161	0.00446	CcSEcCtD
Levosimendan—PDE3A—Platelet homeostasis—NOS3—stomach cancer	0.0016	0.00376	CbGpPWpGaD
Levosimendan—Angiopathy—Doxorubicin—stomach cancer	0.00157	0.00436	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.00153	0.00359	CbGpPWpGaD
Levosimendan—Mental disorder—Doxorubicin—stomach cancer	0.00152	0.00421	CcSEcCtD
Levosimendan—Malnutrition—Doxorubicin—stomach cancer	0.00151	0.00418	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.00146	0.00345	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITGA5—stomach cancer	0.00143	0.00337	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—JUN—stomach cancer	0.00142	0.00334	CbGpPWpGaD
Levosimendan—Nervous system disorder—Methotrexate—stomach cancer	0.00139	0.00387	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—PRKCB—stomach cancer	0.00136	0.0032	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—KISS1R—stomach cancer	0.00136	0.0032	CbGpPWpGaD
Levosimendan—Diarrhoea—Docetaxel—stomach cancer	0.00135	0.00374	CcSEcCtD
Levosimendan—Hypotension—Methotrexate—stomach cancer	0.00133	0.00368	CcSEcCtD
Levosimendan—Diarrhoea—Capecitabine—stomach cancer	0.00131	0.00362	CcSEcCtD
Levosimendan—Nervous system disorder—Epirubicin—stomach cancer	0.0013	0.00362	CcSEcCtD
Levosimendan—Dizziness—Docetaxel—stomach cancer	0.0013	0.00362	CcSEcCtD
Levosimendan—Tachycardia—Epirubicin—stomach cancer	0.0013	0.0036	CcSEcCtD
Levosimendan—Insomnia—Methotrexate—stomach cancer	0.00129	0.00357	CcSEcCtD
Levosimendan—Dizziness—Capecitabine—stomach cancer	0.00126	0.0035	CcSEcCtD
Levosimendan—Vomiting—Docetaxel—stomach cancer	0.00125	0.00348	CcSEcCtD
Levosimendan—Hypotension—Epirubicin—stomach cancer	0.00124	0.00345	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.00124	0.00292	CbGpPWpGaD
Levosimendan—Headache—Docetaxel—stomach cancer	0.00124	0.00343	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—KISS1R—stomach cancer	0.00123	0.0029	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00123	0.0034	CcSEcCtD
Levosimendan—Vomiting—Capecitabine—stomach cancer	0.00121	0.00337	CcSEcCtD
Levosimendan—Nervous system disorder—Doxorubicin—stomach cancer	0.00121	0.00335	CcSEcCtD
Levosimendan—Insomnia—Epirubicin—stomach cancer	0.0012	0.00334	CcSEcCtD
Levosimendan—Tachycardia—Doxorubicin—stomach cancer	0.0012	0.00333	CcSEcCtD
Levosimendan—Headache—Capecitabine—stomach cancer	0.0012	0.00332	CcSEcCtD
Levosimendan—KCNJ11—Neuronal System—HSPA8—stomach cancer	0.00118	0.00278	CbGpPWpGaD
Levosimendan—Nausea—Docetaxel—stomach cancer	0.00117	0.00325	CcSEcCtD
Levosimendan—Hypotension—Doxorubicin—stomach cancer	0.00115	0.00319	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00115	0.00319	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—ACAD8—stomach cancer	0.00114	0.00269	CbGpPWpGaD
Levosimendan—Constipation—Epirubicin—stomach cancer	0.00114	0.00316	CcSEcCtD
Levosimendan—Nausea—Capecitabine—stomach cancer	0.00113	0.00315	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—FGG—stomach cancer	0.00113	0.00266	CbGpPWpGaD
Levosimendan—Insomnia—Doxorubicin—stomach cancer	0.00111	0.00309	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—THBD—stomach cancer	0.00111	0.00261	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—stomach cancer	0.00106	0.0025	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00106	0.00295	CcSEcCtD
Levosimendan—Constipation—Doxorubicin—stomach cancer	0.00105	0.00292	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—PPIA—stomach cancer	0.00102	0.00241	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GMPR2—stomach cancer	0.00102	0.0024	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINA1—stomach cancer	0.000987	0.00232	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HRH4—stomach cancer	0.000982	0.00231	CbGpPWpGaD
Levosimendan—Diarrhoea—Methotrexate—stomach cancer	0.000972	0.0027	CcSEcCtD
Levosimendan—Dizziness—Methotrexate—stomach cancer	0.00094	0.00261	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—IDH3B—stomach cancer	0.000933	0.00219	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SUCLG1—stomach cancer	0.000933	0.00219	CbGpPWpGaD
Levosimendan—Diarrhoea—Epirubicin—stomach cancer	0.00091	0.00253	CcSEcCtD
Levosimendan—Vomiting—Methotrexate—stomach cancer	0.000903	0.00251	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—F2R—stomach cancer	0.000892	0.0021	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SPARC—stomach cancer	0.000892	0.0021	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HRH4—stomach cancer	0.000892	0.0021	CbGpPWpGaD
Levosimendan—Headache—Methotrexate—stomach cancer	0.00089	0.00247	CcSEcCtD
Levosimendan—Dizziness—Epirubicin—stomach cancer	0.000879	0.00244	CcSEcCtD
Levosimendan—PDE3A—GPCR downstream signaling—KISS1—stomach cancer	0.000875	0.00206	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IRF1—stomach cancer	0.000873	0.00206	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NDUFV1—stomach cancer	0.000867	0.00204	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NDUFS1—stomach cancer	0.000867	0.00204	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000858	0.00202	CbGpPWpGaD
Levosimendan—Vomiting—Epirubicin—stomach cancer	0.000845	0.00235	CcSEcCtD
Levosimendan—Nausea—Methotrexate—stomach cancer	0.000844	0.00234	CcSEcCtD
Levosimendan—Diarrhoea—Doxorubicin—stomach cancer	0.000842	0.00234	CcSEcCtD
Levosimendan—Headache—Epirubicin—stomach cancer	0.000833	0.00231	CcSEcCtD
Levosimendan—Dizziness—Doxorubicin—stomach cancer	0.000814	0.00226	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—KISS1—stomach cancer	0.000795	0.00187	CbGpPWpGaD
Levosimendan—Nausea—Epirubicin—stomach cancer	0.00079	0.00219	CcSEcCtD
Levosimendan—Vomiting—Doxorubicin—stomach cancer	0.000782	0.00217	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—BLVRB—stomach cancer	0.000773	0.00182	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PGLS—stomach cancer	0.000773	0.00182	CbGpPWpGaD
Levosimendan—Headache—Doxorubicin—stomach cancer	0.000771	0.00214	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—CD44—stomach cancer	0.000759	0.00179	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GAST—stomach cancer	0.000753	0.00177	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RGS2—stomach cancer	0.000753	0.00177	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPAP2A—stomach cancer	0.000737	0.00173	CbGpPWpGaD
Levosimendan—Nausea—Doxorubicin—stomach cancer	0.000731	0.00203	CcSEcCtD
Levosimendan—PDE3A—Signaling Pathways—GLI3—stomach cancer	0.000729	0.00171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KISS1R—stomach cancer	0.000729	0.00171	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—MAPK1—stomach cancer	0.000701	0.00165	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RBP1—stomach cancer	0.000695	0.00164	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GAST—stomach cancer	0.000683	0.00161	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RGS2—stomach cancer	0.000683	0.00161	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA1—stomach cancer	0.000657	0.00155	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—FBP1—stomach cancer	0.000657	0.00155	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NDUFA2—stomach cancer	0.000657	0.00155	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CKB—stomach cancer	0.000657	0.00155	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PPP2R1A—stomach cancer	0.000645	0.00152	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—PRKCB—stomach cancer	0.000644	0.00152	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLIN2—stomach cancer	0.000618	0.00145	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA2—stomach cancer	0.000601	0.00141	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PGAM1—stomach cancer	0.000586	0.00138	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NT5E—stomach cancer	0.000586	0.00138	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGTR2—stomach cancer	0.00057	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FYN—stomach cancer	0.000569	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WWOX—stomach cancer	0.000567	0.00133	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—F2R—stomach cancer	0.000564	0.00133	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HRAS—stomach cancer	0.000563	0.00132	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDH7A1—stomach cancer	0.000559	0.00131	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLCE1—stomach cancer	0.000559	0.00131	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR1A—stomach cancer	0.000549	0.00129	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—UMPS—stomach cancer	0.000536	0.00126	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ANXA1—stomach cancer	0.00053	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WIF1—stomach cancer	0.000527	0.00124	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HRH4—stomach cancer	0.000527	0.00124	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGTR2—stomach cancer	0.000518	0.00122	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB1—stomach cancer	0.000514	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—F2R—stomach cancer	0.000512	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR1A—stomach cancer	0.000499	0.00117	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PDHA1—stomach cancer	0.000498	0.00117	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ECHS1—stomach cancer	0.000498	0.00117	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKAB1—stomach cancer	0.000486	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAU—stomach cancer	0.000485	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ANXA1—stomach cancer	0.000482	0.00113	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CAV1—stomach cancer	0.000474	0.00112	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—APOA1—stomach cancer	0.000473	0.00111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RNF43—stomach cancer	0.00047	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KISS1—stomach cancer	0.00047	0.0011	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—FADS1—stomach cancer	0.000468	0.0011	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMP—stomach cancer	0.000468	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB1—stomach cancer	0.000466	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PRKCB—stomach cancer	0.000451	0.00106	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SREBF2—stomach cancer	0.000438	0.00103	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—RORA—stomach cancer	0.000433	0.00102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FST—stomach cancer	0.000418	0.000985	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB2—stomach cancer	0.000416	0.000979	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HBEGF—stomach cancer	0.000409	0.000963	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDOB—stomach cancer	0.000406	0.000955	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RGS2—stomach cancer	0.000404	0.00095	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GAST—stomach cancer	0.000404	0.00095	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGG—stomach cancer	0.000383	0.000901	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB2—stomach cancer	0.000378	0.000889	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALOX5—stomach cancer	0.000377	0.000888	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE1—stomach cancer	0.000375	0.000884	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—stomach cancer	0.000375	0.000882	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—DPYD—stomach cancer	0.000371	0.000874	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPP2R1A—stomach cancer	0.00037	0.000871	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKAA1—stomach cancer	0.000368	0.000867	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RHOA—stomach cancer	0.000362	0.000852	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—stomach cancer	0.000358	0.000844	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RBP4—stomach cancer	0.000356	0.000837	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MAPK1—stomach cancer	0.000332	0.000781	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—stomach cancer	0.000328	0.000773	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2A6—stomach cancer	0.000325	0.000764	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKR1C3—stomach cancer	0.000316	0.000743	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO1—stomach cancer	0.000308	0.000724	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HSPB1—stomach cancer	0.000306	0.00072	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR2—stomach cancer	0.000306	0.00072	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BMP2—stomach cancer	0.000303	0.000712	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—F2R—stomach cancer	0.000303	0.000712	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKR1C3—stomach cancer	0.000298	0.0007	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR1A—stomach cancer	0.000295	0.000693	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCB—stomach cancer	0.000285	0.000671	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ANXA1—stomach cancer	0.000284	0.000669	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB1—stomach cancer	0.000275	0.000648	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CD44—stomach cancer	0.000273	0.000642	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HRAS—stomach cancer	0.000266	0.000627	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RPS6—stomach cancer	0.000263	0.000619	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCB—stomach cancer	0.000259	0.000609	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—stomach cancer	0.000258	0.000608	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6ST—stomach cancer	0.000258	0.000607	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK3—stomach cancer	0.000244	0.000575	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HBEGF—stomach cancer	0.000242	0.000569	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK1—stomach cancer	0.000232	0.000547	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPP2R1A—stomach cancer	0.000232	0.000546	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6R—stomach cancer	0.00023	0.000542	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RHOA—stomach cancer	0.000229	0.000539	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—stomach cancer	0.000228	0.000536	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—stomach cancer	0.000224	0.000528	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB2—stomach cancer	0.000223	0.000525	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—stomach cancer	0.00022	0.000517	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP2R1A—stomach cancer	0.000219	0.000515	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMS—stomach cancer	0.000212	0.000498	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—stomach cancer	0.000209	0.000492	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RHOA—stomach cancer	0.000208	0.000489	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SMAD4—stomach cancer	0.000203	0.000478	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—stomach cancer	0.000202	0.000475	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—stomach cancer	0.000201	0.000473	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ERCC2—stomach cancer	0.000197	0.000463	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—stomach cancer	0.000195	0.000459	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FYN—stomach cancer	0.000193	0.000454	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HRAS—stomach cancer	0.000187	0.000439	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—stomach cancer	0.000185	0.000435	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—stomach cancer	0.000182	0.000429	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR2—stomach cancer	0.000181	0.000426	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAV1—stomach cancer	0.00017	0.000401	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOA1—stomach cancer	0.00017	0.0004	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS2—stomach cancer	0.000166	0.00039	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CAV1—stomach cancer	0.000161	0.000378	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOA1—stomach cancer	0.00016	0.000377	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCB—stomach cancer	0.000153	0.00036	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6ST—stomach cancer	0.000152	0.000359	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—stomach cancer	0.00015	0.000353	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APC—stomach cancer	0.000146	0.000345	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK3—stomach cancer	0.00014	0.00033	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6R—stomach cancer	0.000136	0.00032	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—stomach cancer	0.000135	0.000317	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK1—stomach cancer	0.000133	0.000314	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—stomach cancer	0.000133	0.000314	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—stomach cancer	0.000129	0.000303	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—stomach cancer	0.000127	0.0003	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SERPINE1—stomach cancer	0.000127	0.0003	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—stomach cancer	0.000126	0.000297	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RHOA—stomach cancer	0.000123	0.000289	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—stomach cancer	0.000122	0.000286	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—stomach cancer	0.000118	0.000277	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—stomach cancer	0.000116	0.000272	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB2—stomach cancer	0.000114	0.000267	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—stomach cancer	0.000108	0.000254	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HRAS—stomach cancer	0.000107	0.000252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1B—stomach cancer	0.000105	0.000248	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—stomach cancer	0.000103	0.000241	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—stomach cancer	0.0001	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JUN—stomach cancer	0.0001	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—stomach cancer	9.75e-05	0.000229	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1A—stomach cancer	9.72e-05	0.000229	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK8—stomach cancer	9.48e-05	0.000223	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—stomach cancer	8.76e-05	0.000206	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—stomach cancer	8.67e-05	0.000204	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK3—stomach cancer	8.28e-05	0.000195	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—stomach cancer	8.06e-05	0.00019	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK1—stomach cancer	7.88e-05	0.000185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—stomach cancer	7.88e-05	0.000185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—stomach cancer	7.44e-05	0.000175	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—stomach cancer	7.25e-05	0.000171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—stomach cancer	6.84e-05	0.000161	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—stomach cancer	6.62e-05	0.000156	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HRAS—stomach cancer	6.33e-05	0.000149	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—stomach cancer	6.06e-05	0.000142	CbGpPWpGaD
